Edition:
India

Bicycle Therapeutics PLC (BCYC.OQ)

BCYC.OQ on NASDAQ Stock Exchange Global Select Market

7.44USD
16 Aug 2019
Change (% chg)

$-0.09 (-1.20%)
Prev Close
$7.53
Open
$8.09
Day's High
$8.09
Day's Low
$7.44
Volume
774
Avg. Vol
--
52-wk High
$14.89
52-wk Low
$6.90

About

Bicycle Therapeutics PLC, formerly Bicycle Therapeutics Limited, is a clinical-stage biopharmaceutical company. The Company is focused on developing a class of medicines for diseases. The Company’s lead product candidate, BT1718, is a Bicycle Toxin Conjugate (BTC) for oncology indications. BT1718 targets tumors that express... (more)

Overall

Beta: --
Market Cap(Mil.): $158.23
Shares Outstanding(Mil.): 18.00
Dividend: --
Yield (%): --

Financials

Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates